Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Ms. Catherine Szyman es el Chief Executive Officer de Masimo Corp, se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción MASI?
El precio actual de MASI es de $177.8, ha disminuido un 0.35% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Masimo Corp?
Masimo Corp pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Masimo Corp?
La capitalización bursátil actual de Masimo Corp es $9.2B
¿Es Masimo Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 9 analistas han realizado calificaciones de análisis para Masimo Corp, incluyendo 5 fuerte compra, 7 compra, 3 mantener, 0 venta, y 5 fuerte venta